In addition to the CAPS-associated mutations in Cryopyrin/NALP3, polymorphisms in regulatory elements that cause decreased Cryopyrin/NALP3 expression and IL-1β production were recently linked with increased susceptibility to Crohn's disease in humans [28]. Here, NLRP3 is linked to cryopyrin-associated periodic syndrome.